TCL Archive In Brief: Patterns Of care Study Leads “Part Tie” Radiotherapists To Drop Out, Sheline Says July 22, 1977
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
